Cellebrite DI Ltd.
CLBT
$19.85
$0.010.05%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -167.13% | -135.85% | |
| Total Depreciation and Amortization | -- | -- | 3.31% | 22.91% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | 225.70% | 165.52% | |
| Change in Net Operating Assets | -- | -- | 1,466.41% | 1,695.65% | |
| Cash from Operations | -- | -- | 395.98% | 542.51% | |
| Capital Expenditure | -- | -- | 24.16% | -32.83% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 79.48% | -134.45% | |
| Cash from Investing | -- | -- | 75.29% | -30.58% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | 55.80% | 48.64% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -- | 55.80% | 48.64% | |
| Foreign Exchange rate Adjustments | -- | -- | 135.83% | 154.25% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | 274.65% | 307.35% | |